Famed Cardiologist Robert Califf Thwarted by Senate Salmon to Head FDA

By |2016-01-13T16:17:51-08:00January 13th, 2016|We Know Psychiatry|

In a clear signal that medicine and politics make strange bedfellows, a crucial Senate committee on Tuesday, which unanimously approved Dr. Robert M. Califf, a cardiologist and clinical trial expert from Duke University as the commissioner of the Food and Drug Administration, is unlikely to happen soon, because Senator Lisa Murkowski [...]

Role of the FDA in Affordability of Off-Patent Pharmaceuticals

By |2016-01-10T17:06:43-08:00January 10th, 2016|We Know Psychiatry|

Role of the FDA in Affordability of Off-Patent Pharmaceuticals Jeremy A. Greene, MD, PhD; Gerard Anderson, PhD; Joshua M. Sharfstein, MD   In recent weeks, the increasing prices of off-patent pharmaceuticals have been the subject of extensive news coverage and debate, a public meeting at the Department of Health and Human Services (HHS), and hearings in [...]

Psychiatric Publisher Goes Digital

By |2015-12-31T17:17:29-08:00December 31st, 2015|We Know Psychiatry|

For Immediate Release December 31, 2015. Los Angeles CA Contact: James La Rossa Jr., 310.374.1300 MedWorks Media Inc., established in 1994 as one of the largest publishers of journals and educational medical projects about psychiatric medicine, was reconfigured for a 2016 launch as a cutting-edge digital portal and publisher — [...]

Pharmacologic Therapy for Posttraumatic Stress Disorder: Review of Prescriptions and Potential Drug-Drug Interactions in a Military Cohort

By |2015-12-29T16:47:11-08:00December 29th, 2015|We Know Psychiatry|

Pharmacologic Therapy for Post Traumatic Stress Disorder: Review of Prescriptions and Potential Drug-Drug Interactions in a Military Cohort Kara L. Jablonski, PharmD, BCPS; Maria D. Devore, MS; Margaret A. Ryan, MD, MPH; Emily L. Streeter, PsyD, MPH, CPH; Jerlyn C. Tolentino, BA; Angelica A. Klinski, PharmD; and Nahed Bahlawan, PharmD, [...]

What Will Health Care Look like in 20-Years?

By |2015-12-20T20:37:28-08:00December 20th, 2015|We Know Psychiatry|

What Will Health Care Look like in 20-Years? The Microbiome: Beyond the Gut The Microbiome/Inflammation/Infection Link The Microbiome/Environment Link Genomics: The Revolution We've All Been Waiting For Pharmacogenomics Medicine Goes Mobile Immunotherapy ... and more Courtesy Medscape The Microbiome: Beyond the Gut Understanding of the world beneath—the seething, teeming microbial [...]

Opioids for Chronic Pain: Yes or No?

By |2015-12-17T01:16:41-08:00December 17th, 2015|We Know Psychiatry|

At the American College of Rheumatology (ACR) annual meeting, a neurologist and a rheumatologist took the stage to debate whether or not opioid analgesic medications belong in the management of chronic, noncancer pain.[1] John Markman, MD, a neurologist at the University of Rochester Medical Center, took the pro position; Daniel [...]

Serum Insulin-Like Growth Factor-1 in Patients with De Novo, Drug Naïve Parkinson’s Disease: A Meta-Analysis

By |2015-12-14T16:33:03-08:00December 14th, 2015|We Know Psychiatry|

The results of this meta-analysis demonstrate that serum IGF-1 levels were significantly higher in de novo, drug-naïve PD patients compared with healthy controls. Nevertheless, additional endeavors are required to further explore the association between serum IGF-1 levels and diagnosis, prognosis and early therapy for PD.

Go to Top